Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000048

Chief Executive Officer sold 4,156 shares at $32.57 ($135,361)

  • Chief Executive Officer acquired 8,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,500 57,936 D
2024-03-05 Sale : show line 2 in the form 10b5-1 −4,156 $32.57 $135,361 53,780 D
Open-market sales · 4,156 sh · avg $32.57 · $135,361

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 3 in the form 10b5-1 Restricted stock units +54,000 54,000 D
2024-03-01 Grant or award : show line 4 in the form 10b5-1 Stock options (right to buy) +195,500 195,500 D
2024-03-01 Exercise or conversion : show line 5 in the form 10b5-1 Restricted stock units −8,500 17,000 D
Loading xslF345X05/wk-form4_1709673014.xml…